- Home
- FATE vs PEBK Comparison
FATE vs PEBK Comparison
Compare FATE & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- PEBK
- Stock Information
- Founded
- FATE 2007
- PEBK 1912
- Country
- FATE United States
- PEBK United States
- Employees
- FATE N/A
- PEBK N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- PEBK Major Banks
- Sector
- FATE Health Care
- PEBK Finance
- Exchange
- FATE Nasdaq
- PEBK Nasdaq
- Market Cap
- FATE 142.4M
- PEBK 169.6M
- IPO Year
- FATE 2013
- PEBK N/A
- Fundamental
- Price
- FATE $1.42
- PEBK $27.36
- Analyst Decision
- FATE Hold
- PEBK
- Analyst Count
- FATE 10
- PEBK 0
- Target Price
- FATE $6.75
- PEBK N/A
- AVG Volume (30 Days)
- FATE 2.1M
- PEBK 7.3K
- Earning Date
- FATE 03-04-2025
- PEBK 02-12-2025
- Dividend Yield
- FATE N/A
- PEBK 2.34%
- EPS Growth
- FATE N/A
- PEBK 7.58
- EPS
- FATE N/A
- PEBK 2.98
- Revenue
- FATE $13,447,000.00
- PEBK $82,079,000.00
- Revenue This Year
- FATE N/A
- PEBK N/A
- Revenue Next Year
- FATE N/A
- PEBK N/A
- P/E Ratio
- FATE N/A
- PEBK $9.18
- Revenue Growth
- FATE N/A
- PEBK 7.90
- 52 Week Low
- FATE $1.04
- PEBK $23.74
- 52 Week High
- FATE $8.83
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- FATE 48.76
- PEBK 35.31
- Support Level
- FATE $1.43
- PEBK $29.66
- Resistance Level
- FATE $1.81
- PEBK $30.67
- Average True Range (ATR)
- FATE 0.14
- PEBK 0.77
- MACD
- FATE 0.05
- PEBK -0.17
- Stochastic Oscillator
- FATE 39.06
- PEBK 3.22
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.